The status of paediatric medicines initiatives around the world—what has happened and what has not? Kalle HoppuGabriel AnabwaniSaskia N. de Wildt Review Article 06 July 2011 Pages: 1 - 10
A plea for a more epidemiological and patient-oriented pharmacovigilance Veronica ScurtiMarilena RomeroGianni Tognoni Review Article 20 July 2011 Pages: 11 - 19
Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature Jennifer MasonMunir PirmohamedTony Nunn Review Article 22 July 2011 Pages: 21 - 28
The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine Junichi AzumaTomoko HasunumaSumiko Hara Clinical Trial Open access 08 July 2011 Pages: 29 - 37
Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation Yusuke TanigawaraKenji NozawaHisatsugu Tsuda Pharmacodynamics Open access 28 July 2011 Pages: 39 - 53
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study Trine Naalsund AndreassenIngrid EftedalOla Dale Pharmacogenetics Open access 07 July 2011 Pages: 55 - 64
New users of antidepressant medications: first episode duration and predictors of discontinuation Christine Y. LuElizabeth Roughead Pharmacoepidemiology and Prescription 29 June 2011 Pages: 65 - 71
Pattern of asthma medication use among children from a large urban center in Brazil Djanilson Barbosa SantosAlvaro A. CruzMauricio L. Barreto Pharmacoepidemiology and Prescription Open access 30 June 2011 Pages: 73 - 82
Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study Maurits E. L. ArbouwKris L. L. MovigToine C. G. Egberts Pharmacoepidemiology and Prescription Open access 22 July 2011 Pages: 83 - 88
Differences in the consumption rates and regulatory barriers to the accessibility of strong opioid analgesics in Israel and St. Petersburg Alexander M. PonizovskyMichael V. PchelintsevEdwin E. Zvartau Pharmacoepidemiology and Prescription 27 July 2011 Pages: 89 - 95
Comparative adherence to oxybutynin or tolterodine among older patients Tara GomesDavid N. JuurlinkMuhammad M. Mamdani Short Communication 28 June 2011 Pages: 97 - 99
Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect? Amélie DaveluyBrigitte MilpiedThe French Pharmacovigilance Centres Network and The Toxidermia Group of the French Society of Dermatology Short Communication 27 July 2011 Pages: 101 - 105
Erratum to: Physicians’ and pharmacies’ overview of patients’ medication. An analysis of fidelity coefficients Anton PottegårdJesper Hallas Erratum 10 November 2011 Pages: 107 - 107
Clinical impact of fluvoxamine-mediated long QTU syndrome Amir M. NiaKristina M. DahlemFikret Er Letter to the Editors 29 June 2011 Pages: 109 - 111